Miriam Kim

2.8k total citations
47 papers, 570 citations indexed

About

Miriam Kim is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Miriam Kim has authored 47 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 16 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Miriam Kim's work include CAR-T cell therapy research (21 papers), Immune Cell Function and Interaction (12 papers) and Acute Myeloid Leukemia Research (6 papers). Miriam Kim is often cited by papers focused on CAR-T cell therapy research (21 papers), Immune Cell Function and Interaction (12 papers) and Acute Myeloid Leukemia Research (6 papers). Miriam Kim collaborates with scholars based in United States, Canada and South Korea. Miriam Kim's co-authors include John Provias, Mark Bernstein, Joel Finkelstein, Paul Nolan, John F. DiPersio, Julie Ritchey, Saad S. Kenderian, Michael Klichinsky, Marco Ruella and Saar Gill and has published in prestigious journals such as Nature Communications, Blood and Analytical Chemistry.

In The Last Decade

Miriam Kim

44 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miriam Kim United States	14	290	140	139	81	79	47	570
Carl‐Magnus Högerkorp Sweden	11	105 0.4×	264 1.9×	309 2.2×	45 0.6×	30 0.4×	16	662
Francesca Ferrera Italy	15	102 0.4×	141 1.0×	309 2.2×	39 0.5×	30 0.4×	30	559
Anton Neschadim Canada	16	146 0.5×	253 1.8×	182 1.3×	160 2.0×	26 0.3×	27	629
Claudia Haftmann Germany	13	138 0.5×	243 1.7×	578 4.2×	50 0.6×	44 0.6×	17	883
Yasushi Yoshimura Japan	16	219 0.8×	378 2.7×	272 2.0×	20 0.2×	31 0.4×	44	846
Muharrem Müftüoğlu United States	14	264 0.9×	171 1.2×	166 1.2×	57 0.7×	10 0.1×	54	587
Nobuhiko Imahashi Japan	14	306 1.1×	111 0.8×	283 2.0×	91 1.1×	13 0.2×	41	622
Mary Paniagua United States	11	150 0.5×	86 0.6×	278 2.0×	23 0.3×	38 0.5×	15	591
Daniel C. Zedek United States	16	274 0.9×	259 1.9×	130 0.9×	71 0.9×	57 0.7×	41	762
Erik F. Williams United States	3	388 1.3×	170 1.2×	224 1.6×	76 0.9×	15 0.2×	4	556

Countries citing papers authored by Miriam Kim

Since Specialization

Citations

This map shows the geographic impact of Miriam Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Kim more than expected).

Fields of papers citing papers by Miriam Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Kim. The network helps show where Miriam Kim may publish in the future.

Co-authorship network of co-authors of Miriam Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Kim. A scholar is included among the top collaborators of Miriam Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Kim. Miriam Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Jin Kyun, et al.. (2024). Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trial. The Lancet Rheumatology. 6(6). e352–e360. 4 indexed citations

Crees, Zachary, Miriam Kim, Michael D. Bern, et al.. (2023). Immune Adjuvant Therapy With Interleukin-7 in a Lymphopenic Patient With Aplastic Anemia and Mucormycosis. Critical Care Explorations. 5(10). e0990–e0990. 1 indexed citations

Xiang, Jingyu, Jessica M. Devenport, Karl Staser, et al.. (2023). An “Off-the-Shelf” CD2 Universal CAR-T Therapy Combined with a Long-Acting IL-7 for T-Cell Malignancies. Blood. 142(Supplement 1). 764–764. 3 indexed citations

Xiang, Jingyu, Jessica M. Devenport, Karl Staser, et al.. (2023). An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies. Leukemia. 37(12). 2448–2456. 24 indexed citations

Kim, Miriam. (2023). Making normal hematopoiesis invisible to CAR T cells. Trends in cancer. 9(12). 983–984. 2 indexed citations

Ferraro, Francesca, Marianna B. Ruzinova, Christopher A. Miller, et al.. (2022). Decitabine salvage for <i>TP53</i>-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy. Haematologica. 107(7). 1709–1713. 7 indexed citations

Kim, Miriam, Reyka G. Jayasinghe, Jessica M. Devenport, et al.. (2022). A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity. Nature Communications. 13(1). 3296–3296. 62 indexed citations

Kim, Miriam, Matthew Cooper, Miriam T. Jacobs, et al.. (2021). CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy. JCI Insight. 6(16). 28 indexed citations

Klichinsky, Michael, Marco Ruella, Olga Shestova, et al.. (2020). Abstract PR07: Human chimeric antigen receptor (CAR) macrophages for cancer immunotherapy. Cancer Immunology Research. 8(4_Supplement). PR07–PR07. 2 indexed citations

10.

Klichinsky, Michael, Marco Ruella, Olga Shestova, et al.. (2017). Abstract 4575: Chimeric antigen receptor macrophages (CARMA) for adoptive cellular immunotherapy of solid tumors. Cancer Research. 77(13_Supplement). 4575–4575. 9 indexed citations

11.

Kenderian, Saad S., Marco Ruella, Olga Shestova, et al.. (2016). Ruxolitinib Prevents Cytokine Release Syndrome after CART Cell Therapy without Impairing the Anti-Tumor Effect in a Xenograft Model. Blood. 128(22). 652–652. 31 indexed citations

12.

Kim, Miriam, et al.. (2014). Pharmacoeconomic Implications of Lenalidomide Maintenance Therapy in Multiple Myeloma. Oncology. 87(4). 224–231. 11 indexed citations

13.

Kim, Miriam, et al.. (2013). Updates on the treatment of human epidermal growth factor receptor type 2-positive breast cancer. Current Opinion in Obstetrics & Gynecology. 26(1). 27–33. 5 indexed citations

14.

Graham, Daniel J. & Miriam Kim. (2008). Information and Classical Thermodynamic Transformations. The Journal of Physical Chemistry B. 112(34). 10585–10593. 3 indexed citations

15.

Kim, Miriam, James M. Drake, & Paul Milgram. (2000). Virtual Tape Measure for the Operating Microscope: System Specifications and Performance Evaluation. Computer Aided Surgery. 5(3). 148–155. 2 indexed citations

16.

Kim, Miriam, James M. Drake, & Paul Milgram. (2000). Virtual tape measure for the operating microscope: System specifications and performance evaluation. Computer Aided Surgery. 5(3). 148–155. 4 indexed citations

17.

Kim, Miriam, Paul Nolan, & Joel Finkelstein. (2000). Evaluation of the 11th rib extrapleural—retroperitoneal approach to the thoracolumbar junction. Journal of Neurosurgery Spine. 93(1). 168–174. 24 indexed citations

18.

Kim, Miriam, et al.. (1997). Cavernous Malformation Presenting As an Extra-axial Cerebellopontine Angle Mass: Case Report. Neurosurgery. 40(1). 187–190. 40 indexed citations

19.

Kim, Miriam, et al.. (1997). Cavernous Malformation Presenting As an Extra-axial Cerebellopontine Angle Mass: Case Report. Neurosurgery. 40(1). 187–190. 7 indexed citations

20.

Kim, Miriam & Mark Bernstein. (1996). Current treatment of cerebral metastasis. Current Opinion in Neurology. 9(6). 414–418. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact